Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01445587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00051116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06924424. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT03309111. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
ClinicalTrials.gov study NCT05020236. IPD Sharing: YES. Countries: 26. Publications: 0.
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00431340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06235229. IPD Sharing: YES. Countries: 1. Publications: 0.
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05065047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT01372540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
ClinicalTrials.gov study NCT07107529. IPD Sharing: NO. Countries: 0. Publications: 0.
A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT06700395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
ClinicalTrials.gov study NCT01018927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
ClinicalTrials.gov study NCT00182663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT03445663. IPD Sharing: YES. Countries: 2. Publications: 0.
Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05411497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00022282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR
ClinicalTrials.gov study NCT02387879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04956302. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Combination PS-341 and Thalidomide in Multiple Myeloma
ClinicalTrials.gov study NCT00083460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma
ClinicalTrials.gov study NCT02221479. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.